Product Information
OMEGA-3 ETHYL ESTERS 1 GM CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1711 per EA under NDC 31722093612. Its NADAC has been published 392 times since Apr 3, 2019.
FDA first approved this application on Feb 25, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722093612
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEGA-3-ACID ETHYL ESTERSApproval Type
Generic (ANDA)
FDA Application
ANDA207420FDA Approved
2/25/2019
TE Code
AB
On Market Since
2/25/2019
Pharmacological Classes
Price Statistics
The NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has been published 392 times since Apr 3, 2019, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1711 per EA |
|---|---|
| All-time high | $0.2890 (Sep 11, 2019) |
| All-time low | $0.1537 (Jan 18, 2023) |
| 52-week high | $0.1726 |
| 52-week low | $0.1652 |
| Median price | $0.1798 |
| Average price | $0.1957 |
| Largest weekly change | -19.9% (Mar 17, 2021) |
| Weeks tracked | 392 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Omega-3-acid ethyl esters market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omega-3-acid ethyl esters market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Omega-3 Fatty Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEGA-3 ETHYL ESTERS 1 GM CAP?
The current National Average Drug Acquisition Cost (NADAC) for OMEGA-3 ETHYL ESTERS 1 GM CAP, manufactured by Camber Pharmaceuticals Inc., is $0.1711 per EA (NDC 31722093612), effective Sep 30, 2026.
How has the price of OMEGA-3 ETHYL ESTERS 1 GM CAP changed over time?
Over the history we have for it, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has declined 34.8%. It has been tracked across 392 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for OMEGA-3 ETHYL ESTERS 1 GM CAP?
Since Apr 3, 2019, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has ranged from a low of $0.1537 (Jan 18, 2023) to a high of $0.2890 (Sep 11, 2019), with a median of $0.1798 per EA.
Are there cheaper alternatives to OMEGA-3 ETHYL ESTERS 1 GM CAP?
No other NADAC-published product currently shares the active ingredient and strength of OMEGA-3 ETHYL ESTERS 1 GM CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEGA-3 ETHYL ESTERS 1 GM CAP?
OMEGA-3 ETHYL ESTERS 1 GM CAP (NDC 31722093612) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.